These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 23449637)

  • 21. [Influence of donor activating or inhibitory KIR on prognosis of unmanipulated allogeneic hematopoietic stem cell transplantation].
    Liang ZY; Ren HY; Cen XN; Qiu ZX; Wang LH; Ou JP; Li Y; Wang MJ; Wang WS; Xu WL; Dong YJ; Yin Y; Sun YH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Feb; 21(1):155-60. PubMed ID: 23484711
    [TBL] [Abstract][Full Text] [Related]  

  • 22. KIR gene mismatching and KIR/C ligands in liver transplantation: consequences for short-term liver allograft injury.
    Legaz I; López-Álvarez MR; Campillo JA; Moya-Quiles MR; Bolarín JM; de la Peña J; Salgado G; Gimeno L; García-Alonso AM; Muro M; Miras M; Alonso C; Álvarez-López MR; Minguela A
    Transplantation; 2013 Apr; 95(8):1037-44. PubMed ID: 23478359
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NK cell killer Ig-like receptor repertoire acquisition and maturation are strongly modulated by HLA class I molecules.
    Sleiman M; Brons NH; Kaoma T; Dogu F; Villa-Forte A; Lenoble P; Hentges F; Kotsch K; Gadola SD; Vilches C; Zimmer J
    J Immunol; 2014 Mar; 192(6):2602-10. PubMed ID: 24554773
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of KIR2DS1 does not significantly contribute to NK cell cytotoxicity in HLA-C1/C2 heterozygous haplotype B donors.
    Baltner K; Kübler A; Pal M; Balvociute M; Mezger M; Handgretinger R; André MC
    Int Immunol; 2017 Nov; 29(9):423-429. PubMed ID: 29099970
    [TBL] [Abstract][Full Text] [Related]  

  • 25. KIR2DS1-positive NK cells mediate alloresponse against the C2 HLA-KIR ligand group in vitro.
    Chewning JH; Gudme CN; Hsu KC; Selvakumar A; Dupont B
    J Immunol; 2007 Jul; 179(2):854-68. PubMed ID: 17617576
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Large spectrum of HLA-C recognition by killer Ig-like receptor (KIR)2DL2 and KIR2DL3 and restricted C1 SPECIFICITY of KIR2DS2: dominant impact of KIR2DL2/KIR2DS2 on KIR2D NK cell repertoire formation.
    David G; Djaoud Z; Willem C; Legrand N; Rettman P; Gagne K; Cesbron A; Retière C
    J Immunol; 2013 Nov; 191(9):4778-88. PubMed ID: 24078689
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Autologous and allogeneic HLA KIR ligand environments and activating KIR control KIR NK-cell functions.
    Morvan M; David G; Sébille V; Perrin A; Gagne K; Willem C; Kerdudou N; Denis L; Clémenceau B; Folléa G; Bignon JD; Retière C
    Eur J Immunol; 2008 Dec; 38(12):3474-86. PubMed ID: 19016529
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The natural killer cell-mediated killing of autologous dendritic cells is confined to a cell subset expressing CD94/NKG2A, but lacking inhibitory killer Ig-like receptors.
    Della Chiesa M; Vitale M; Carlomagno S; Ferlazzo G; Moretta L; Moretta A
    Eur J Immunol; 2003 Jun; 33(6):1657-66. PubMed ID: 12778484
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of the inhibitory KIR ligand HLA-Bw4 and HLA-C expression levels in the recognition of leukemic cells by Natural Killer cells.
    Verheyden S; Ferrone S; Mulder A; Claas FH; Schots R; De Moerloose B; Benoit Y; Demanet C
    Cancer Immunol Immunother; 2009 Jun; 58(6):855-65. PubMed ID: 18841361
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of missing killer cell immunoglobulin-like receptor ligands in T cell replete peripheral blood stem cell transplantation from HLA-identical siblings.
    Clausen J; Kircher B; Auberger J; Schumacher P; Ulmer H; Hetzenauer G; Wolf D; Gastl G; Nachbaur D
    Biol Blood Marrow Transplant; 2010 Feb; 16(2):273-80. PubMed ID: 19857587
    [TBL] [Abstract][Full Text] [Related]  

  • 31. IL-18-induced CD83+CCR7+ NK helper cells.
    Mailliard RB; Alber SM; Shen H; Watkins SC; Kirkwood JM; Herberman RB; Kalinski P
    J Exp Med; 2005 Oct; 202(7):941-53. PubMed ID: 16203865
    [TBL] [Abstract][Full Text] [Related]  

  • 32. KIR2DS5 allotypes that recognize the C2 epitope of HLA-C are common among Africans and absent from Europeans.
    Blokhuis JH; Hilton HG; Guethlein LA; Norman PJ; Nemat-Gorgani N; Nakimuli A; Chazara O; Moffett A; Parham P
    Immun Inflamm Dis; 2017 Dec; 5(4):461-468. PubMed ID: 28685972
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cellular and molecular basis of haploidentical hematopoietic stem cell transplantation in the successful treatment of high-risk leukemias: role of alloreactive NK cells.
    Locatelli F; Pende D; Mingari MC; Bertaina A; Falco M; Moretta A; Moretta L
    Front Immunol; 2013; 4():15. PubMed ID: 23378843
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Killer Ig-like receptor ligand mismatch directs NK cell expansion in vitro.
    Rose MJ; Brooks AG; Stewart LA; Nguyen TH; Schwarer AP
    J Immunol; 2009 Oct; 183(7):4502-8. PubMed ID: 19748981
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phenotypic and functional activation of hyporesponsive KIRnegNKG2Aneg human NK-cell precursors requires IL12p70 provided by Poly(I:C)-matured monocyte-derived dendritic cells.
    Curran SA; Romano E; Kennedy MG; Hsu KC; Young JW
    Cancer Immunol Res; 2014 Oct; 2(10):1000-10. PubMed ID: 25023628
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expansion of NKG2A-LIR1- natural killer cells in HLA-matched, killer cell immunoglobulin-like receptors/HLA-ligand mismatched patients following hematopoietic cell transplantation.
    Rathmann S; Glatzel S; Schönberg K; Uhrberg M; Follo M; Schulz-Huotari C; Kaymer M; Veelken H; Finke J; Fisch P
    Biol Blood Marrow Transplant; 2010 Apr; 16(4):469-81. PubMed ID: 20044012
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human natural killer cells: origin, receptors, function, and clinical applications.
    Moretta L; Montaldo E; Vacca P; Del Zotto G; Moretta F; Merli P; Locatelli F; Mingari MC
    Int Arch Allergy Immunol; 2014; 164(4):253-64. PubMed ID: 25323661
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Natural killer cell immunity after transplantation.
    Terszowski G; Passweg JR; Stern M
    Swiss Med Wkly; 2012; 142():w13700. PubMed ID: 23135787
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Engineering lymph node homing of ex vivo-expanded human natural killer cells via trogocytosis of the chemokine receptor CCR7.
    Somanchi SS; Somanchi A; Cooper LJ; Lee DA
    Blood; 2012 May; 119(22):5164-72. PubMed ID: 22498742
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of KIRs and KIR ligands in hematopoietic transplantation.
    Velardi A
    Curr Opin Immunol; 2008 Oct; 20(5):581-7. PubMed ID: 18675345
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.